| FOR PATIENTS AND THE PUBLIC |
| |
|
| |
| FOR RESEARCHERS AND HEALTH CARE PROFESSIONALS |
|
|
|
| Scholar Profiles |
| |
| Congratulations to the Research Scholars Program Class of 2007 |
| |
2007 – 2008 Astellas Foundation USA Scholars
Trinity J. Bivalacqua, M.D., Ph.D. - Johns Hopkins Hospital
“Molecular Basis of Priapism: Nitric Oxide Imbalance”
Sean Corbett, M.D. - Baylor College of Medicine
“Improved Detection of Chromosomal Anomalies in Gonadal Dysgenesis”
Scott Gilbert, M.D. - University of Michigan
“Assessing Patient-Centered Survivorship Care in Prostate Cancer”
2007 – 2008 Scholars
Maureen Basha, Ph.D. - University of Pennsylvania
“Molecular Mechanisms Regulating Vaginal Smooth Muscle Function”
Sponsors: Society for Urodynamics and Female Urology/AUA Foundation
Martin Hager, Ph.D. - Children's Hospital Boston
“Membrane Heterogeneity in Akt Activation in Prostate Cancer”
Sponsors: AUA Foundation Prostate Cancer Fund/GlaxoSmithKline
Anthony Joshua, M.D. - Princess Margaret Hospital, Univ. of Toronto
“Implications and Consequences of Telomere Dysfunction in Prostate Cancer”
Sponsor: AUA Foundation
2007 – 2009 Scholars
Collene Jeter, Ph.D. – Univ. of Texas - M.D. Anderson Cancer Center
“Novel Strategy to Isolate Label-Retaining Cells from Prostate Tumors”
Sponsor: Sanofi-Aventis
Wujiang Liu, Ph.D. - University of Iowa
“Role of Mast Cells in Antigen-mediated Autoimmune Cystitis”
Sponsors: Interstitial Cystitis Association/Ortho Women’s Health and Urology
Laura Perin, Ph.D. - Childrens Hospital Los Angeles
“In vivo Application of Amniotic Fluid Stem Cells for Kidney Regenerati”
Sponsor: Dornier MedTech
|
|
| Support Research |
| |
A primary objective of the AUA Foundation is to fund research that improves patient care and outcomes. There are many important areas of urologic disease that need more research, such as: prostate cancer, the second leading cause of cancer-related deaths among American men; bladder cancer, the fifth most commonly diagnosed non-skin malignancy among Americans; kidney cancer, the diagnosis of which has steadily increased by 2% each year for the last 65 years; infertility, in which half of all cases in the United States can be attributed to the male; and erectile dysfunction, a common complication of diabetes which affects 70% of men with the disease.
Our Research Scholars Program is just one example of the type of research the AUA Foundation funds. By donating to the AUA Foundation and designating those funds to our research efforts, you will improve the lives of the many patients who suffer from debilitating urologic conditions.
Donate today.
|
| Hot News & Items |
| |
NIDDK Seeking Director of KUH Division
The NIDDK recently posted a job announcement for the Director of Kidney, Urologic,
and Hematologic Diseases (KUH) Division. The KUH Director sets scientific priorities
and makes decisions on budget allocations as they relate to research programs in kidney,
urologic, and hematologic diseases. These duties and responsibilities of this position make
it extremely crucial to urology research and key to our primary goal of increasing the level
of federal research funding. The NIDDK seeks candidates who have a significant track record of
scientific research achievement, senior management experience, and outstanding communication skills.
The position is currently posted on USAjobs.com (click to be linked to the posting) and will be advertised
in publications, including the Journal of Urology, the New England Journal of Medicine, and the Journal of
the American Society of Nephrology. The closing date for the posting is August 31, 2007.
Center for Scientific Review Hosts Open House Workshops
http://cms.csr.nih.gov/AboutCSR/OpenHouses.htm
The Center for Scientific Review will host six one-day Open House Workshops in 2007
at the National Institutes of Health (NIH) to solicit input from leaders of the scientific
community and other stakeholders on the alignment of its Integrated Review Groups (IRGs)
and component study sections, which assess NIH grant applications for scientific and technical merit.
The workshop on renal and urologic diseases is scheduled for August 24, 2007.
This workshop provides an excellent opportunity for representatives from the urologic research
community and patient advocacy groups to gain insight and give input into the federal grant funding process.
|
|
| Clinical Trials |
| |
| Before a pharmaceutical company can initiate testing in humans, it must conduct extensive pre-clinical or laboratory research. This research typically involves years of experiments in animals and humans. The medical care is often provided free to the patient. Patients may also be paid a small fee to participate in a clinical trial.
Use the links below to find information on clinical trials and search for trials in your area. |
| |
| UrologyHealth.org Clinical Trials Resource Center |
| National Cancer Institute Clinical Trials |
| Let your voice be heard! |
| |
| Every day, millions of men, women, children and their
families suffer in silence and shame with debilitating urologic conditions. |
| |
 |
Incontinence is a leading reason people are forced to enter nursing homes - with the aging of the American population,
this problem will become a major issue for many families and patients. |
|
As many as 10 million children are affected by bladder problems, and some forms can be deadly. |
|
Prostate cancer is the leading non-cutaneous cancer in men, with more than 230,000 new cases and 27,000 deaths expected in 2006.
Treatments for prostate cancer have serious side effects, including incontinence and erectile dysfunction. |
| |
| Congress must act now because: |
| |
|
Baby boomers could be independent longer without being forced into nursing homes. |
|
Families could spend less on long-term care. |
|
We could reduce federal health-care costs. |
|
Promising scientific research could move forward with additional funding. |
| |
| |
The time has come to change the way we think about urologic disease! |
| |
| Write to Congress |
| |
| Let your representatives know that you support the Training and Research in Urology (TRU) Act and other important health-care issues.
Simply enter your ZIP code® into the box and click "GO." |
| |
|
|
|
| Research Scholar Program |
| |
 Online Registration |
| AUA Foundation Research Scholars Program |
| |
| Since 1975, the Research Scholars Program has provided over 460 scholarships and awards to young men and women who are interested in pursuing a career in urologic research. The AUA Foundation Research Scholars Program is important to urologic research because it provides an opportunity for young scientists to begin a career in urologic research at a time when many urology departments across the country are faced with budget challenges that limit research opportunities. |
| Researchers have been awarded scholarships through a variety of programs and fellowships. Many of those scholars remain in academic urology today, continuing to build upon the foundation of experience and knowledge gained during their research fellowships. |
| |
| Click here for more information or to apply for the 2010 Research Scholars Program |
| |
| Congratulations to the Research Scholars Program Class of 2009 |
| |
|
| |
| 2009 AUA Section Endowment Fund Scholars |
|  | Scott Delacroix, M.D.
Institution: MD Anderson Cancer Center
Sponsor: AUA South Central Section
Title: "Evaluation of Nicotinamide N-Methyltransferase Modulation on Chemotherapeutic Susceptibilityof Clear Cell Renal Cell Carcinoma"
Mentor: Christopher Wood, M.D.
more information
Patients battling metastatic kidney cancer often face poor outcomes. The cancer is inherently resistant to standard chemotherapy drugs and radiation; and it lacks long-term responses to the newer classes of chemotherapy agents. Dr. Delacroix’s research aims to target and silence an enzyme that we believe is involved in the cancer’s resistance to chemotherapy. He will also explore the cancer’s ability to adapt and escape the effects of newer drugs. His efforts will provide a scientific basis for chemotherapy sequences and improve the efficiency of currently available drugs. The ultimate goal of this research is to better overall care of patients with this disease.
Click www.scsauanet.org for more information on Dr. Scott Delacroix's sponsor, the AUA South Central Section.
|
|
 | Rong Liu, Ph.D.
Institution: Albany Medical College
Sponsor: AUA Northeastern Section
Title: "PEMPA1 Promotes Cell Proliferation Through Down-Regulating p21Waf1/Cip1 in Prostate
Mentor: Ceshi Chen, Ph.D.
more information
The principle objective of Dr. Liu’s work is to develop new molecular targets for prostate cancer prevention, diagnosis, and therapy. Recently, she identified a novel molecule, PMEPA1, as a potential oncogenic protein in prostate tumorigenesis. She will utilize a variety of approaches, with combinations of molecular, cellular techniques and animal model, to investigate the role of PMEPA1 in prostate cancer development. Unraveling the mechanisms will be a promising step towards better understanding prostate carcinogenesis, and providing a novel molecular target for future diagnosis and anti-prostate tumor therapies.
Click www.nsaua.org for more information on Dr. Rong Liu's sponsor, the AUA Northeastern Section.
|
|
 | Ted Skolarus, M.D.
Institution: University of Michigan
Sponsor: AUA North Central Section
Title: "Prostate Cancer Expenditures: Variation and Implications"
Mentor: John Wei, M.D.
more information
Because of its prolonged clinical course, prostate cancer is among the most prevalent malignancies with over 2 million survivors in the United States alone. Thus, understanding how to best care for prostate cancer survivors is important for quality care and has considerable economic implications. In light of the generally drawn out course of the continuing care phase of prostate cancer survivorship, identifying the variation in physician practice patterns affecting continuing care expenditures is likely to yield future opportunities to improve the quality, efficiency and effectiveness of care, as well as reduce the costs of care. Dr. Skolarus’ project will use data from the linkage of two large population-based data sources: the Surveillance, Epidemiology, and End Results (SEER) cancer registries data and the Medicare enrollment and claims files, to examine the influence of patient and physician level factors on the economics of continuing care for prostate cancer survivors.
Click www.ncsaua.org for more information on Dr. Ted Skolarus's sponsor, the AUA North Central Section.
|
|
 | Jared Whitson, M.D.
Institution: University of California - San Francisco
Sponsor: AUA Western Section
Title: "Double Stranded-RNA Mediated Gene Activation and Regulation of Kidney Cancer"
Mentor: Rajvir Dahiya, Ph.D.
more information
Working with kidney cancer cells, Dr. Whitson’s research hopes to provide further insight into how RNA molecules effect the expression of genes. Cancer cells have the ability to hijack the processes of cell proliferation and death. First, Dr. Whitson will look into how these two processes can be recovered. Insights may lead to the development of new therapies. Also, he will work toward translating findings in cell cultures to animal models. This is an important first step toward understanding the role RNA molecules play in gene expression, which may later be useful in the treatment of human diseases.
Click www.wsaua.org for more information on Dr. Jared Whitson's sponsor, the AUA Western Section.
|
|
| | | 2009 Astellas USA Foundation Scholars |
|  | Smitha Dutt, Ph.D.
Institution: University of California, Davis School of Medicine
Sponsor: Astellas USA Foundation
Title: "Role of Trefoil Factor 1(TFF1) in Castration Resistant Prostate Cancer"
Mentor: Allen Gao, M.D., Ph.D.
more information
Prostate cancer, the second most predominant cancer among men in the United States, is often treated with Androgen deprivation therapy (ADT). Unfortunately, after ADT treatment, prostate cancer relapses within 18 months. The cancer cells learn to survive without androgens and begin thriving once again in the patient. Thus far science has been unable to fully define and understand this process.
The Trefoil Factor 1 gene (the TFF1 gene) plays an important role in cancer cells ability to grow without androgen. Dr. Dutt’s study intends to examine the role of the TFF1 gene in three ways: first, by looking at how the gene effects the growth rate of tumors in cell cultures and animal models; second, by observing how the absence of the gene reduces tumor formation in prostate growth; and third, to watch how the TFF1 gene interacts with androgen receptors. These experiments will help increase the understanding of the function of TFF1 in prostate cancer and determine the effect of hormones on its expression. Through this study she hopes to further understand the process of prostate cancer relapse and pave the way for future research that will improve prostate cancer therapy.
Click www.astellas.com/en/csr/community/support.html for more information on Dr. Smitha Dutt's sponsor, the Astellas USA Foundation.
|
|
 | Amit Gupta, M.D., M.P.H.
Institution: Memorial Sloan Kettering Cancer Center
Sponsor: Astellas USA Foundation
Title: "Significance of Prostate-Specific Antigen and Kallikrein 2 (hK2) in Prostate Cancer"
Mentor: Hans Lilja, M.D., M.P.H.
more information
Prostate cancer is the most common cancer among men but still most men die with rather than of their cancer. Although screening is an attractive option an unequivocal benefit of screening has not been shown. In addition the appropriate age to initiate screening, the screening interval and the PSA cut-offs to recommend prostate biopsies are controversial.
Dr. Gupta will use Swedish population based data from a healthy, unscreened population, to evaluate whether PSA and other biomarkers measured at age 44-55 years predict subsequent prostate cancer metastases or death. In addition he will develop prediction tools to predict an individual man’s probability of prostate cancer metastases or death based on either a single or repeated measure of PSA at age 44 – 55 years. This may lead to development of new screening guidelines based on individualized risk assessment.
Click www.astellas.com/en/csr/community/support.html for more information on Dr. Amit Gupta's sponsor, the Astellas USA Foundation.
|
|
 | Xiaogang Jiang, M.D., Ph.D.
Institution: University of Washington
Sponsor: Astellas USA Foundation
Title: "The Role of Inadequate Elastin Deposition in Erectile Dysfunction"
Mentor: Claire Yang, M.D. and Kanchan Chitaley,
Ph.D.
more information
Dr. Jiang’s research is based on the hypothesis that proper elastin, a protein in elastic tissue, deposits and fiber formation are critical for healthy erectile function. When elastin is poorly deposited in the penile tissue erectile dysfunction occurs. He has also seen this poor elastin distribution in type II diabetic mice, tissue damaged by smoking, and aging tissue. Through his research of type II diabetic mice, he hopes to gain knowledge that will have implications primarily for erectile dysfunction; but that might also give insight into smoking damaged tissue and aging tissue.
Click www.astellas.com/en/csr/community/support.html for more information on Dr. Xiaogang Jiang's sponsor, the Astellas USA Foundation.
|
|
| | | 2009-2011 Research Scholars |
|  | Guang Jia, Ph.D.
Institution: The Ohio State University
Sponsor: EUSA Pharma (USA), Inc.
Title: "Phase 0 MRI Study to Detect in Vivo Protein Levels in Prostate Cancer"
Mentor: Michael Knopp, M.D., Ph.D. and Robert R Bahnson, M.D.
more information
Prostate cancer is shown to have elevated levels of mobile proteins. Recently, a novel technique called “amide-proton-transfer magnetic resonance imaging” has been developed to detect mobile protein levels in the human body. Our study is designed to determine whether this technique is feasible to detect elevated mobile protein levels in prostate cancer.
Dr. Jia plans to non-invasively image 30 prostate cancer patients within two years. He will determine whether this technique can be used to detect tumor size and location in the prostate. This study is an important step before this technique can be applied for diagnosing prostate cancer and monitoring treatment response.
Click www.eusapharma.com for more information on Dr. Guang Jia's sponsor, EUSA Pharma (USA), Inc..
|
|
 | Ye Sun, M.D., Ph.D.
Institution: Children's Hospital Boston
Sponsor: Dornier MedTech
Title: "Homeodomain Transcription Factor and the Mammalian Lower Urinary Tract Development"
Mentor: X. Sean Li, Ph.D.
more information
Disorders resulting from the anomalous differentiation of the urogenital and anorectal tracts account for a significant proportion of congenital birth defects. However, the underlying molecular and cellular etiology is poorly understood. Dr. Sun’s laboratory at Children’s Boston studies the fundamental cellular and molecular mechanisms underlying urinary tract development using both mouse genetic models and molecular biochemical approaches. Dr. Sun’s proposed studies will focus on identifying genetic pathways and novel signaling factors that underlie normal urorectal septation and that are subverted in congenital abnormalities. We believe that these studies will reveal the molecular underpinnings of lower urinary tract development and identify potential avenues of preventive and/or therapeutic interventions of LUT-related disorders.
Click www.dornier.com for more information on Dr. Ye Sun's sponsor, Dornier MedTech.
|
|
 | Jun Yan, Ph.D.
Institution: Columbia University
Sponsor: Dornier MedTech
Title: "Analyses of Early Stage Prostate Carcinogenesis: Targeting the NFKB Pathway for Early Intervention"
Mentor: Cory Abate-Shen, Ph.D.
more information
Chronic inflammation has been shown to be linked to carcinogenesis of many malignancies, including prostate cancer. NFKB, which plays a key role during the process of inflammation, has emerged as an important player for the initiation and progression of cancer development, suggesting that targeting NFKB signaling could be an excellent for chemoprevention and therapy. Dr. Yan’s research will investigate NFKB inflammatory-associated signaling pathway in an inducible prostate cancer mouse model. The goal of his project is to provide evidence to support NFKB signaling for prevention of prostate carcinogenesis.
Click www.dornier.com for more information on Dr. Jun Yan's sponsor, Dornier MedTech.
|
|
| | | 2009-2010 Research Scholars |
|  | HaiHong Jiang, M.D., Ph.D.
Institution: Cleveland Clinic
Sponsor: Society for Urodynamics and Female Urology (SUFU)
Title: "Electrostimulation After Delivery Injury to Treat Urinary Incontinence"
Mentor: Margot Damaser, Ph.D.
more information
During child birth the external urethral sphincter (EUS) and the pudendal nerve, which controls the EUS, can be compressed and injured. These injuries strongly correlate with the later development of Stress Urinary Incontinence (SUI).
It has been shown that electrostimulation of nerves near nerve injuries can promote nerve growth. Dr. Jiang’s hypothesis is that electrostimulation of injured pudendal nerves will improve recovery after childbirth. By testing this procedure in a variety of ways, he hopes to optimize and develop functional electrical treatment as a preventative measure for SUI. Dr. Jiang’s project will enable researchers to further clarify how SUI develops after childbirth as well as to test a potential treatment.
Click www.sufuorg.com for more information on Dr. HaiHong Jiang's sponsor, the Society for Urodynamics and Female Urology.
|
|
 | Joshua Meeks, M.D., Ph.D.
Institution: Northwestern University
Sponsor: sanofi-aventis
Title: "The Role of MicroRNAs in Prostate Development"
Mentor: James Jameson, M.D.
more information
The focus of Dr. Meeks’ research is to investigate prostate gland development as a model system for prostate growth and cancer. He will study a novel class of small molecules that are called microRNAs (miRNAs). These molecules have a dynamic role in cell signaling in nearly every species from worms to humans. Dr. Meeks and the team in his lab at Northwestern hypothesize that miRNAs are responsible for the rapid response of androgen hormones in growth and differentiation of the embryonic prostate gland. From this research, Dr. Meeks hopes to establish a fundamental link between miRNAs and prostate growth as a new and basic mechanism that has implications in the treatment of benign and malignant diseases of the prostate, including BPH.
Click www.sanofi-aventis.us for more information on Dr. Joshua Meeks's sponsor, sanofi-aventis.
|
|
|
| |
Congratulations to our continuing 2008-2010 Research Scholars
Scholar: Stephen Culp, M.D., Ph.D.
Institution: The University of Texas - M. D. Anderson Cancer Center
Project: Action and Resistance of Targeted Therapy in Non-Clear Cell RCC
Mentor: Christopher Wood, M.D.
Sponsor: Kidney Cancer Association
Scholar: Sathish Kasina, Ph. D.
Institution: University of Michigan
Project: Role of the CXCL12/CXCR4 Axis in ADAM-mediated E-cadherin Cleavage
Mentor: Jill A. Macoska, Ph.D.
Sponsor: Dornier MedTech
Scholar: Kristina Penniston, Ph. D.
Institution: University of Wisconsin
Project: Medical Nutrition Therapy for Urolithiasis: Assessing Quality of Life
Mentor: Stephen Y. Nakada, M.D.
Sponsor: AUA Foundation Innovative Research Fund
Scholar: Matthew Tanner, Ph. D.
Institution: Ordway Research Institute, Inc.
Project: Paracrine Activation of Wnt Signaling in Prostate Cancer Cells
Mentor: Ralph Buttyan, Ph.D.
Sponsor: AUA Foundation Prostate Research Fund
Scholar: Junqiang Tian, Ph. D.
Institution: Stanford University
Project: Inorganic Selenium Selectively Inhibits Prostate Cancer and Sensitizes Prostate Cancer to Radiation and Chemotherapy
Mentor: Susan J. Knox, Ph.D., M.D.
Sponsor: Dornier MedTech
Scholar: Sapna Vijayakumar, Ph.D.
Institution: Mt. Sinai School of Medicine
Project: Role of the Paracrine Acting wnts in Prostate Cancer-Induced Bone Meta
Mentor: Stuart A. Aaronson, M.D.
Sponsor: Novartis
|
| |
| AUA Foundation/Astellas Rising Star in Urology Research Award |
| |
|
Competition for board-certified or board-eligible urologists with externally funded,
peer-reviewed career development awards for salary supplementation.
|
| Pfizer/AUA Fellowship in Urology |
| |
| One-year, $70,000 fellowships for clinical research in
male sexual medicine and erectile dysfunction for board-certified or board-eligible urologists. |
| |
| AUA Foundation Bridge Awards |
| |
| Provides up to $15,000 to
assist AUA members continue research efforts for peer-reviewed grant applications that are not funded. |
| |
| AUA Foundation/NIDDK/NCI Surgeon-Scientist Award |
| |
| Provides salary supplementation for board-certified or board-eligible urologists
with National Institute of Diabetes & Digestive & Kidney Diseases
(NIDDK) or National Cancer Institute (NCI) career development funding in the first year of funding. |
| |
| Grantscraft Course |
| |
| This course prepares applicants for the development of a competitive grant application and provides strategies to maximize the opportunities to obtain research funding. Topics that are covered include: selection of research topics, how to manage the application process, strategies for writing a successful grant and the role of collaborators and mentors. |
| |
| NIH Grants Tutorials |
| |
| These tutorials developed by the National Institute of Allergy and Infectious Diseases help biomedical investigators, especially new ones, plan, write, and apply for the basic NIH research project grant, the R01. Research Project Grants support a focused research program conducted by a principal investigator with or without collaborators, postdoctoral trainees, graduate students and/or technicians. |
| http://www.niaid.nih.gov/ncn/grants/ |
| |
| NIH New Investigators Program |
| |
| The Office of Extramural Research (OER) has established a new web site that articulates NIH's continuing commitment to new investigators. The site describes current policies, data related to the influx of new investigators, resources that new investigators can use to understand and work with the NIH and helpful hints that might be useful in constructing a first application for NIH support. |
|
http://grants1.nih.gov
|
| |
| Urologic Diseases in America |
| |
| "Urologic Diseases in America" is a report on the prevalence, incidence, treatment and economic impact of urologic disease in the United States by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). This interim presentation covers urolithiasis, benign prostatic hyperplasia, urinary incontinence, urinary tract infection and sexually transmitted diseases. The full report will include pre-natal hydronephrosis, male reproductive health, urethral diseases, interstitial cystitis, chronic prostatitis and cancers of the prostate, bladder, kidney and testis. |
| http://kidney.niddk.nih.gov/statistics/uda/ |
| |
|
| |
| Resources for the Development of Early-Career Scientists
|
| |
Beginning scientists face a variety of challenges in launching their careers. Good research skills are only one part of the formula for success. They have to hire and lead a research team, efficiently manage a lab, find grant support, publish, and mentor. The publications and links on this Web site can help new investigators "make the right moves" as they launch their careers and assist those who take on the important task of providing early-career researchers with scientific management training. |
| http://www.hhmi.org/resources/labmanagement/ |
| |
| The NCI Grant Process Book |
| |
This publication provides a general description of how a grant is awarded and administered. Although the discussion relates to the National Cancer Institute (NCI), the grants process is similar within the other National Institutes of Health (NIH) awarding components. |
| www3.cancer.gov/admin |
| |
| Centers for Disease Control and Prevention |
| |
To help achieve its mission of promoting health and quality of life, the Centers for Disease Control and Prevention (CDC) [www.cdc.gov] provides postgraduate training and service programs for health scientists of diverse educational backgrounds and other funding through its Procurement and Grants Office (PGO) [www.cdc.gov/about/funding.htm] |
|
| Department of Defense |
| |
The Department of Defense’s [http://cdmrp.army.mil] Office of the Congressionally Directed Medical Research Programs (CDMRP) manages Congressional Special Interest Medical Research Programs (CSI) in specified areas. Current programs include the Prostate Cancer Research Program and Minority and Underserved Populations Program. Look for annual program announcement(s) as well as for current funding for postdoctoral candidates, idea grants and clinical trials on their web site. |
|
| Department of Veterans Affairs |
| |
| The Office of Research and Development aspires to lead the Veterans Health Administration in providing unequaled health care value to veterans. That endeavor is made ever greater — and challenged by — the changing dynamics of health care, which is always evolving as consumers demand quality for their dollar, and medical technology leaps ahead of our capacity to manage it.
|
| |
- VA Merit Award: Must have 5/8ths VA appointment—awards three to five years
- Research Career Development Award: 5/8ths appointment not required, provides support for biomedical, clinical, rehabilitation, and health services research. Goal is to attract new investigators to VA system.
- Details available at www.research.va.gov
|
|
| Grants.gov |
| |
A policy directive from the Office of Federal Financial Management required that all Federal agencies post grant opportunities on line as of November 7, 2003. www.Grants.gov allows users to electronically find and apply for competitive grant opportunities from all Federal grant-making agencies. The "Resources" section also provides access to useful grants-related information and links. |
|
| National Cancer Institute |
| |
| The National Cancer Institute (NCI) [www.cancer.gov] supports training programs in the basic, clinical and population science disciplines to provide a base of personnel who can participate in basic and epidemiological research, clinical trials and cancer treatment programs. The NCI funds grants in research training, career development and cancer education [www.cancer.gov/researchandfunding], including the Ruth L. Kirschstein National Research Service Award components (F32 and T32) and Loan Repayment contracts. Other cancer research funding agencies can be found on this site [www.nci.nih.gov]. |
|
| National Institute of Diabetes & Digestive & Kidney Diseases |
| |
The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [www.niddk.nih.gov] funds urologic research in a number of areas; including pediatric urology, sexual dysfunction, prostate and bladder research, and the genitourinary effects of diabetes mellitus, spinal-cord injury and multiple sclerosis. The NIDDK Training and Careers Programs offer research training and career development awards in the clinical and basic sciences for predoctoral and postdoctoral training and career development in the broad areas of research supported by NIDDK. Of particular program interest are training and development of underrepresented minority investigators for retention in academic research and the training of future independent researchers. Visit this site for funding and research ppportunities [www.niddk.nih.gov/fund/fund.htm]. |
|
| National Institutes of Health |
| |
The National Institutes of Health (NIH) [www.nih.gov] is the principal health research agency of the federal government. It is a component of the Department of Health and Human Services and provides funds to organizations outside the NIH to accomplish program goals—grants, cooperative agreements and contracts. The NIH awards research grants for terms ranging from one to five years and make up the largest category of funding provided by the NIH. |
|
| National Institute on Aging |
| |
The National Institute on Aging (NIA) [www.nia.nih.gov] supports studies on the mechanisms of aging, the processes of aging, aging and the nervous system and aging in relation to health and disease. The NIA supports four extramural research programs [www.nia.nih.gov/ResearchInformation]: Biology of Aging, Behavioral and Social Research, Neuroscience and Neuropsychology of Aging, and Geriatrics and Clinical Gerontology. |
|
| Foundations |
| |
Hundreds of millions of dollars in research funding is also available through private and non-profit organizations. The research grant programs at these organizations support the efforts of both established and young investigators, and sometimes target research where funding may not be available from “traditional” sources. |
| |
|
|
|
| Events |
|
No records were found.
|
| How to Get a Grant |
| |
Writing grant proposals is a complicated and time-consuming process. Successful grant writing involves the coordination of several activities, including planning, searching for data and resources, writing and packaging a proposal, submitting a proposal to a funder, and follow-up. Here are some helpful tools to assist biomedical investigators, especially new ones, plan, write and apply for funding opportunities. |
| |
| View our 2007 Grantscraft presentation |
| |
| Other Sources of Research Funding |
| |
The AUA Foundation is always exploring potential research funding mechanisms, including travel awards to key urologic meetings. As these opportunities arise, additional information will be posted here and published in our electronic research newsletter, EUREKA! (Expanding Urology Research, Education, Knowledge And Funding!). Click here to subscribe to EUREKA!. |
| |
|
|
Foundation Supported Research
